Monte Rosa Therapeutics, Inc. - Common Stock — 貸借対照表 (NASDAQ:GLUE) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 366.33 M342.39 M303.75 M438.73 M448.66 M 負債合計 18.81 M70.98 M124.5 M215.8 M215.6 M 純資産合計 347.51 M271.41 M179.25 M222.94 M233.06 M 負債および純資産合計 366.33 M342.39 M303.75 M438.73 M448.66 M 有利子負債合計 ————— 純負債 —————

ニュース

Monte Rosa Therapeutics (GLUE) Reports Q1 Loss, Misses Revenue Estimates

Myriad Genetics (MYGN) Reports Q1 Loss, Misses Revenue Estimates

Monte Rosa Therapeutics, Inc. (GLUE) Presents at AACR Annual Meeting 2026 - Slideshow (NASDAQ:GLUE) 2026-04-23

Monte Rosa Therapeutics (GLUE) Reports Q4 Loss, Misses Revenue Estimates

Agenus (AGEN) Q4 Earnings and Revenues Surpass Estimates

Monte Rosa Therapeutics (GLUE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

モンテ・ローザ・セラピューティクスの決算発表、収益減少の中で注目集まる

Monte Rosa Therapeutics earnings on deck amid revenue decline

Dunn Edmund, principal accounting officer, sells Monte Rosa (GLUE) shares for $2496

Kura Oncology (KURA) Reports Q4 Loss, Misses Revenue Estimates

モンテ・ローザ、前立腺がん試験結果で株価上昇

Monte Rosa shares rise on prostate cancer trial results